Mantle Cell Lymphoma Trials

MCL Biobank observational study

Description:
Establishing a Biobank and database as a national resource for characterising Indolent and Aggressive forms of Mantle Cell Lymphoma, an Observational study

Phase:
N/A

Start:
09/02/2015

End:
31/10/2017

2 years

Locations:
Plymouth Hospitals NHS Trust

Treatments:
None, observational only

Objectives:
To identify a subgroup of patients with indolent mantle cell lymphoma

Funder
Bloodwise

Enrollment Criteria:
Newly diagnosed patients with MCL aged 16 and over. Able to give written, informed consent.

Health Professionals requiring information on trials and access to our professional section of the website can register here

« Back to list of trials

Plymouth Hospitals NHS Trust UKCRC Plymouth University Peninsula

Beechwood Communications Web Design  Web Design by Beechwood